CRIZALK 250 mg is primarily used to treat a specific type of lung cancer called non-small cell lung cancer (NSCLC). CRIZALK 250 mg (Crizotinib) works by blocking certain enzymes involved in the growth and spread of cancer cells. By doing this, Crizotinib can help slow down the progression of the cancer and help improve the quality of life for those affected by the disease.
CRIZALK 250 mg (Crizotinib)
$1,850.00 – $5,199.00
Active Ingredient | Crizotinib |
---|---|
Indication | Non-small cell lung cancer |
Manufacturer | Pfizer India Ltd |
Packaging | 60 capsules in 1 bottle |
Strength | 250 mg |
Delivery Time | 6 To 15 days |
- 15% Off Coupan Code GOOD15
- Data Privacy and Security
- Free Shipping on Orders Over $199
Variation | Price | Quantity | Add To Cart |
---|---|---|---|
60 Capsule/s | $1,850.00 |
|
Add to cart |
120 Capsule/s | $3,550.00 |
|
Add to cart |
180 Capsule/s | $5,199.00 |
|
Add to cart |
Reviews
There are no reviews yet.